Mineralys’ Phase 3 blood pressure pill data support potential FDA approval

Topline pivotal data suggest that Mineralys Therapeutics’ experimental hypertension pill is a good prospect not only for approval but also for widespread adoption as a treatment for patients whose condition has not responded to other ...